EQS-News

VARON Reinforces Commitment to Seasonal Respiratory Wellness During Allergy Season Across Europe 07.05.2026, 16:25 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: VARON / Key word(s): Miscellaneous
VARON Reinforces Commitment to Seasonal Respiratory Wellness During Allergy Season Across Europe

07.05.2026 / 16:25 CET/CEST
The issuer is solely responsible for the content of this announcement.


LONDON, May 7, 2026 /PRNewswire/ -- As allergy season impacts millions across Europe, VARON is highlighting the importance of seasonal respiratory wellness and accessible oxygen support for individuals experiencing increased breathing sensitivity during high pollen periods.

With spring allergies affecting users in the United Kingdom, Germany, France, Italy, and Spain, demand for home and portable travel oxygen continues to rise. VARON noted that many individuals are seeking flexible options that support comfort at home and during outdoor activity when seasonal triggers are at their peak.

A key product in the company's lineup is the VARON VP-6 Continuous Portable Oxygen Concentrator, a compact oxygen concentrator designed for continuous oxygen delivery. The device offers adjustable continuous flow from 1 to 6 liters per minute and oxygen concentration up to 90% at setting one, supporting users who need consistent respiratory assistance during periods of increased seasonal discomfort.

Unlike pulse-dose systems, the VP-6 provides continuous oxygen flow. At the 6 L/min setting, its built-in nebulizer function activates automatically, allowing combined oxygen and nebulization support without additional equipment. This makes it suitable for users managing seasonal respiratory challenges alongside ongoing therapy needs.

Weighing under 8 pounds, the VP-6 oxygen machine is designed for portability with a rechargeable battery, travel bag, car adaptor, and remote control. Its quiet operation (≤ 45 dB) makes it suitable for use at home, during travel, or in public spaces.

During allergy season, VARON notes that simple habits can also help support easier breathing, such as monitoring pollen levels, keeping indoor air clean with regular ventilation or filtration, staying hydrated, and limiting outdoor exposure during high-pollen hours when possible.

VARON stated that the VP-6 oxygen machine reflects growing demand for reliable portable oxygen concentrator solutions that balance continuous performance with everyday usability. The company added that its broader mission remains focused on expanding access to cost-effective oxygen concentrators and respiratory solutions worldwide, including regions across Asia and the Americas, alongside its growing presence in Europe.

In line with seasonal respiratory wellness awareness, VARON continues supporting users through devices as well as educational resources, guides, and care information to help individuals better understand and manage breathing comfort during allergy season.

For more information, visit VARON Official Website.

Media Contact:
Website: VARON Oxygen Concentrators
Email: support@varoninc.uk

Cision View original content:https://www.prnewswire.co.uk/news-releases/varon-reinforces-commitment-to-seasonal-respiratory-wellness-during-allergy-season-across-europe-302765781.html

rt.gif?NewsItemId=EN53895&Transmission_Id=202605071022PR_NEWS_EURO_ND__EN53895&DateId=20260507


07.05.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2323430  07.05.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer